Stock Groups

White House says Biden has yet to make a decision about new FDA commissioner By Reuters


© Reuters. FILEPHOTO: This sign can be seen at White Oak headquarters of Food and Drug Administration in Maryland on August 29, 2020. REUTERS/Andrew Kelly/File Photograph

WASHINGTON (Reuters] – White House press Secretary Jen Psaki stated on Thursday that U.S. president Joe Biden is still waiting to decide on the nominee for head of Food and Drug administration.

Many media outlets have reported that Biden’s attention is on Robert Califf who was the former FDA Commissioner. But Psaki replied “not yet” to a question about whether President Obama has taken a final decision.

Psaki said, “We’re certainly keen to complete this within a short time.”

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts, buy/sell signal, and quotes. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



Mike Robinson
Mike covers the financial, utilities and biotechnology sectors for Street Register. He has been writing about investment and personal finance topics for almost 12 years. Mike has an MBA in Finance from Wake Forest University.